In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis

被引:28
作者
Carrillo-Muñoz, AJ
Guglietta, A
Palacín, C
Casals, J
del Valle, O
Guardià, C
Rodríguez, V
Quindós, G
机构
[1] Hosp Gen Valle Hebron, Dept Microbiol Asesoria Cient & Invest Aplicada, Barcelona, Spain
[2] Hosp Gen Valle Hebron, Ctr Invest & Desarrollo, Grp Ferrer Int, Barcelona, Spain
[3] Hosp Gen Valle Hebron, Microbiol Serv, Barcelona, Spain
[4] Ctr Atencio Primaria, Badalona, Spain
[5] Univ Basque Country, Fac Med & Odontol, Dept Inmunol Microbiol & Parasitol, E-48080 Bilbao, Spain
关键词
antifungals; clotrimazole; dermatophytes; econazole; fluconazole; isoconazole; itraconazole; ketoconazole; miconazole; Scopulariopsis; sertaconazole; terbinafine; tioconazole;
D O I
10.1159/000082631
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
We have tested 250 strains belonging to 15 species of clinically important dermatophytes and Scopulariopsis against ten antifungal drugs using an agar diffusion method (NeoSensitabs(TM), Rosco, Taastrup, Denmark). Some of the experimental factors were adapted to dermatophyte development, such as temperature ( 28 vs. 35 degreesC) and time of incubation ( 2 - 5 days vs. 21 - 74 h). The antifungals used are itraconazole, ketoconazole, miconazole, clotrimazole, sertaconazole, terbinafine, tioconazole, fluconazole, isoconazole and econazole. Except for fluconazole, all the drugs tested have shown to be highly effective, especially sertaconazole and terbinafine. Percentages of susceptibility ranged between 94% for terbinafine, 87.6% for sertaconazole and 86.4% clotrimazole; 81.6% econazole; 42.8% fluconazole; 57.2% isoconazole; 78.4% itraconazole; 74.4% ketoconazole; 73.3% miconazole, and 85.2% for tioconazole. Percentages of resistance were similar between sertaconazole and terbinafine (4%) but in contrast to the 48% obtained for fluconazole. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 37 条
[1]
Common superficial fungal infections in patients with AIDS [J].
Aly, R ;
Berger, T .
CLINICAL INFECTIOUS DISEASES, 1996, 22 :S128-S132
[2]
BREGA EF, 2000, 40 INT C ANT AG CHEM, P354
[3]
Butty P, 1995, J MED VET MYCOL, V33, P403
[4]
SENSITIVITY OF SOME STRAINS OF THE GENUS EPIDERMOPHYTON TO DIFFERENT ANTIFUNGAL AGENTS [J].
CABANES, FJ ;
ABARCA, L ;
BRAGULAT, M ;
BRUGUERA, T .
MYCOPATHOLOGIA, 1989, 105 (03) :153-156
[5]
Carrillo Munoz Alfonso-Javier, 1997, Revista Iberoamericana de Micologia, V14, P50
[6]
Carrillo-Munoz A J, 1999, Rev Esp Quimioter, V12, P181
[7]
Carrillo-Munoz A J, 1999, Rev Esp Quimioter, V12, P58
[8]
In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility [J].
Carrillo-Muñoz, AJ ;
Fernández-Torres, B ;
Cárdenes, DC ;
Guarro, J .
CHEMOTHERAPY, 2003, 49 (05) :248-251
[9]
Ciclopiroxolamine:: In vitro antifungal activity against clinical yeast isolates [J].
Carrillo-Muñoz, AJ ;
Brió, S ;
Alonso, R ;
del Valle, O ;
Santos, P ;
Quindós, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (05) :375-379
[10]
Sertaconazole:: In-vitro antifungal activity against vaginal and other superficial yeast isolates [J].
Carrillo-Muñoz, AJ ;
Brió, S ;
Quindós, G ;
Palacín, C ;
Guglietta, A ;
Espinel-Ingroff, A .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (05) :555-562